BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2014
View Archived Issues
Bayer HealthCare and University of Oxford collaborate on endometriosis and uterine fibroid research
Read More
MRC Technology and AstraZeneca renew collaboration to identify novel targets
Read More
Medicure acquires minority position in Apicore
Read More
Researchers present a novel insulin analogue with improved glycemic control
Read More
Japanese approval for Dovobet to treat psoriasis vulgaris
Read More
MRZ-9547 assessed in Parkinson's disease models, enters phase I in healthy subjects
Read More
Zalviso MAA submitted in Europe
Read More
Early clinical results presented for PEX-168
Read More
Lundbeck patents novel nAChR alpha7 PAMs
Read More
Merck KGaA prepares new BTK inhibitors
Read More
Novartis synthesizes novel pyridone derivatives for tuberculosis
Read More
New CDK8/CCNC inhibitors synthesized by Roche
Read More
Researchers at Roche and Genentech divulge novel RORC modulators for arthritis
Read More
Nexavar approved in Canada for differentiated thyroid cancer
Read More
Promising phase I data presented for a number of oncolytic immunotherapy candidates
Read More
Japan approves first all-oral interferon- and ribavirin-free HCV treatment
Read More
Endo and BioDelivery Sciences report data from phase III BEMA buprenorphine trial
Read More
Data safety monitoring recommends continuation of phase IIb brilacidin trial
Read More
BeiGene initiates phase I trial of PARP inhibitor BGB-290
Read More
Cardio3 BioSciences enrolls 120th patient in the phase III CHART-1 study
Read More
Celladon provides update on Mydicar development
Read More
Mekinist approved in E.U. for metastatic melanoma with a BRAF V600 mutation
Read More
Anoro Ellipta approved in Japan for COPD
Read More
FDA approves NovoSeven RT for Glanzmann's thrombasthenia
Read More
FDA breakthrough therapy designation granted to cell therapy for leukemia
Read More